Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nortech Systems (NSYS) Gains from Sales and Divestitures (2019 - 2025)

Nortech Systems recorded quarterly Gains from Sales and Divestitures of $24141.0 in Q4 2025, little changed quarter-over-quarter from $24141.0 in Q3 2025, and up 46.31% year-over-year from $16500.0 in Q4 2024.

Nortech Systems' Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $24141.0 for Q4 2025.

  • In Q4 2025, Gains from Sales and Divestitures rose 46.31% year-over-year to $24141.0; the TTM figure through Dec 2025 stood at $24141.0 (up 46.31% YoY), while the FY2025 annual figure was $24141.0, up 46.31% from the prior year.
  • Gains from Sales and Divestitures came in at $24141.0 for Q4 2025 at Nortech Systems, roughly flat from $24141.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $24141.0 in Q2 2025 to a low of $9000.0 in Q1 2023.
  • A 3-year average of $16129.4 and a median of $16500.0 in 2024 frame the typical range for Gains from Sales and Divestitures.
  • Across the five-year window, Gains from Sales and Divestitures soared 66.67% in 2024 and surged 46.31% in 2025, its largest moves.
  • Nortech Systems' Gains from Sales and Divestitures stood at $10500.0 in 2023, then soared by 57.14% to $16500.0 in 2024, then soared by 46.31% to $24141.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $24141.0, $24141.0, and $24141.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nortech Systems 48.92 Mn 46.72 Mn 4.70 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 24,141.00
Dec 31, 2025 24,141.00
Sep 30, 2025 24,141.00
Sep 30, 2025 24,141.00
Jun 30, 2025 24,141.00
Jun 30, 2025 24,141.00
Dec 31, 2024 16,500.00
Dec 31, 2024 16,500.00
Sep 30, 2024 16,500.00
Sep 30, 2024 16,500.00
Jun 30, 2024 16,500.00
Jun 30, 2024 16,500.00
Mar 31, 2024 15,000.00
Mar 31, 2024 15,000.00
Dec 31, 2023 10,500.00
Dec 31, 2023 10,500.00
Sep 30, 2023 10,500.00
Sep 30, 2023 10,500.00
Jun 30, 2023 10,500.00
Jun 30, 2023 10,500.00
Mar 31, 2023 9,000.00
Mar 31, 2023 9,000.00
Sep 30, 2019 25,000.00
Sep 30, 2019 25,000.00
Mar 31, 2019 132,500.00
Mar 31, 2019 132,500.00